Scilex Holding (SCLX) Q3 2025 earnings summary

Executive summary

• Net revenue for Q3 2025 was $10.6M, down from $14.4M in Q3 2024, mainly due to lower ZTlido sales volume.

• Net loss for Q3 2025 was $257.8M, compared to $4.4M in Q3 2024; YTD net loss was $327.9M vs. $66.3M prior year.

• Significant increase in selling, general, and administrative expenses, largely from $140M in reverse recapitalization costs and $24.5M in advisory/financing expenses.

• Company completed the Semnur Business Combination and adopted a cryptocurrency treasury strategy, acquiring $200M in Bitcoin.

Financial highlights

• Q3 2025 net revenue: $10.6M (down $3.8M YoY); YTD net revenue: $25.5M (down $16.2M YoY).

• Q3 2025 net loss: $257.8M; YTD net loss: $327.9M.

• Cash and cash equivalents at September 30, 2025: $0.9M.

• Accumulated deficit at September 30, 2025: $888.7M.

• Operating cash flow for nine months ended September 30, 2025: $21.3M.

• Significant non-cash charges: $60.3M loss on derivative liabilities, $36.5M loss on fair value of debt/liabilities, $8.3M gain on equity investments, $4.7M gain on digital assets.

Outlook and guidance

• Management expects continued net losses and negative cash flows as investments in commercialization and R&D continue.

• Substantial doubt exists about the ability to continue as a going concern for the next 12 months without additional funding.

• Plans to seek additional capital through equity, debt, collaborations, or strategic transactions.